The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial

BACKGROUND: In the Italian Breast Cancer Intergroup Studies (IBIS) 3 phase III trial, we compared cyclophosphamide, methotrexate, 5-fluorouracil (CMF) alone to sequential epirubicin/CMF regimens in patients with rapidly proliferating early breast cancer (RPEBC). We performed a post hoc analysis in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bravaccini, Sara, Bronte, Giuseppe, Scarpi, Emanuela, Ravaioli, Sara, Maltoni, Roberta, Mangia, Anita, Tumedei, Maria Maddalena, Puccetti, Maurizio, Serra, Patrizia, Gianni, Lorenzo, Amaducci, Laura, Biglia, Nicoletta, Bounous, Valentina, Paradiso, Angelo Virgilio, Silvestrini, Rosella, Amadori, Dino, Rocca, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047424/
https://www.ncbi.nlm.nih.gov/pubmed/32158505
http://dx.doi.org/10.1177/1758835919888999

Ejemplares similares

Ejemplares similares